Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
|Videos|August 13, 2022
Exciting Developments for Difficult to Treat Depression
Author(s)Michael E. Thase, MD
What are the latest treatments in difficult to treat depression?
Advertisement
Michael E. Thase, MD, gives a summary of his exciting talk on difficult to treat depression from the
Dr Thase is a professor of psychiatry at the Perelman School of Medicine University of Pennsylvania.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
2
Positive Topline Phase 3 Study Results: Lumateperone for Manic Episodes in Bipolar I Disorder
3
New Analyses of HLP003 for the Adjunctive Treatment of MDD
4
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
5